HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pyloromyotomy in a patient with paramyotonia congenita.

AbstractUNLABELLED:
A 2-mo-old infant with paramyotonia congenita was scheduled for pyloromyotomy and repair of inguinal hernia. Diagnosis of paramyotonia congenita was done with positive family history, myotonia at eyelids, provocation by cold, and electromyogram analysis. Anesthesia was induced via face mask with sevoflurane at 4 minimum alveolar anesthetic concentration in oxygen. Tracheal intubation was attempted without a neuromuscular relaxant. Anesthesia was maintained with sevoflurane at 0.5 minimum alveolar anesthetic concentration in oxygen and remifentanil infusion at a rate of 0.2 micro g. kg(-1). min(-1). After discontinuation of sevoflurane and remifentanil, the patient was awake and had full recovery of muscle activity.
IMPLICATIONS:
The literature concerning general anesthesia in paramyotonic patients is limited. We report a case of paramyotonia congenita in a 2-mo-old male infant undergoing surgery for pyloric stenosis and inguinal hernia after an uneventful anesthesia.
AuthorsBinnaz Ay, Arzu Gerçek, Varlk I Doğan, Gürsu Kyan, Ylmaz F Göğüş
JournalAnesthesia and analgesia (Anesth Analg) Vol. 98 Issue 1 Pg. 68-69 (Jan 2004) ISSN: 0003-2999 [Print] United States
PMID14693588 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anesthetics, Inhalation
  • Methyl Ethers
  • Sevoflurane
Topics
  • Anesthesia, Inhalation
  • Anesthetics, Inhalation
  • Electromyography
  • Hernia, Inguinal (complications, surgery)
  • Humans
  • Infant
  • Male
  • Methyl Ethers
  • Myotonic Disorders (complications, diagnosis, genetics)
  • Pedigree
  • Pylorus (surgery)
  • Sevoflurane

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: